We studied factors that may add to the high risk of atherosclerosis in
kidney transplant recipients. Plasma lipoprotein concentrations and p
arameters of low density lipoprotein (LDL) oxidation were determined i
n 19 clinically stable kidney recipients and 19 healthy controls. Plas
ma triglycerides and total cholesterol were increased in the patients.
High density lipoprotein-cholesterol (HDL-c) was in the normal range.
The mean LDL diameter was smaller in patients than in controls (236.5
+/- 7.3 Angstrom vs. 247.5 +/- 11.6 Angstrom, P < 0.002), which was d
ue to a higher frequency of the LDL subclass pattern B in the patients
than in controls (58% vs. 28%). The lag lime of copper-induced in vit
ro LDL oxidation was shorter in patients than in controls (101 +/- 23
min vs. 148 +/- 81 min. P = 0.02). The titer and concentration of auto
antibodies against malondialdehyde-modified (MDA-LDL) determined by EL
ISA were higher in the patients than in the controls. This difference
was found in both IgG (titer + 9%, concentration + 75%; P < 0.05) and
IgM (titer + 35%, concentration + 102%; P < 0.001). Based on these res
ults, we propose that there is in vitro and in vivo evidence of enhanc
ed LDL oxidation in patients post-renal transplantation. This might re
present one cause for the clinical finding of advanced atherosclerosis
in these patients.